Home > Articles > Published articles > Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting : > Comments
 
 
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting : PROTEC - Berger, Thomas (Universitätsklinik für Neurologie) ; Brochet, B. (Groupe Hospitalier Pellegrin Hôpital Pellegrin) ; Brambilla, L. (IRCCS Foundation Neurological Institute Carlo Besta) ; Giacomini, P.S. (Montreal Neurological Institute Hospital) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Vasco Salgado, A (Hospital Professor Doutor Fernando Fonseca) ; Su, R (Biogen, USA) ; Bretagne, A (Biogen International GmbH) ; Universitat Autònoma de Barcelona. Departament de Medicina
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>

Similar records

UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with